Related references
Note: Only part of the references are listed.Polo-like kinase 1 phosphorylates and regulates Bcl-xL during pironetin-induced apoptosis
Y. Tamura et al.
ONCOGENE (2009)
Evaluation of Polo-like Kinase 1 inhibition on the G2/M checkpoint in Acute Myelocytic Leukaemia
Christine Didier et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
MS-275, a novel histone deacetylase inhibitor with selectivity against HDAC1, induces degradation of FLT3 via inhibition of chaperone function of heat shock protein 90 in AML cells
Chie Nishioka et al.
LEUKEMIA RESEARCH (2008)
AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo
Jing Yang et al.
BLOOD (2007)
ZD6474 induces growth arrest and apoptosis of human leukemia cells, which is enhanced by concomitant use of a novel MEK inhibitor, AZD6244
C. Nishioka et al.
LEUKEMIA (2007)
A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia
Takayuki Ikezoe et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells
Takayuki Ikezoe et al.
LEUKEMIA RESEARCH (2007)
In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase 1
Timothy J. Lansing et al.
MOLECULAR CANCER THERAPEUTICS (2007)
The antitumor effects of sunitinib (formerly SU11248) against a variety of human hematologic malignancies: enhancement of growth inhibition via inhibition of mammalian target of rapamycin signaling
Takayuki Ikezoe et al.
MOLECULAR CANCER THERAPEUTICS (2006)
HIV-1 protease inhibitor ritonavir potentiates the effect of 1,25-dihydroxyvitamin D3 to induce growth arrest and differentiation of human myeloid leukemia cells via down-regulation of CYP24
Takayuki Ikezoe et al.
LEUKEMIA RESEARCH (2006)
Opinion - Targeting polo-like kinase 1 for cancer therapy
K Strebhardt et al.
NATURE REVIEWS CANCER (2006)
Polo-like kinase 1 expression is a prognostic factor in human colon cancer
Wilko Weichert et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Polo-like kinase isoforms in breast cancer:: expression patterns and prognostic implications
W Weichert et al.
VIRCHOWS ARCHIV (2005)
Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-κB signal pathways
T Ikezoe et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Polo-like kinases and oncogenesis
F Eckerdt et al.
ONCOGENE (2005)
Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells
T Ikezoe et al.
BLOOD (2004)
Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation
K Ando et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers
T Takahashi et al.
CANCER SCIENCE (2003)
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
PD Kottaridis et al.
BLOOD (2001)
The human polo-like kinase, PLK, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase
AK Roshak et al.
CELLULAR SIGNALLING (2000)
Share Paper
